Jonathan Mark Hopper sold $358K of Vericel (VCEL)

Executed Sep 2 2025, disclosed Sep 3 2025, 1 day later.

Value, as filed

$358K

10,000 sh × $35.77

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 3 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jonathan Mark Hopper Chief Medical Officer profile →

Jonathan Mark Hopper (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Vericel Corporation (VCEL). The largest single filing was $450K of VCEL (10,000 sh across 2 lots, as filed), executed Jun 26.

The name

VCEL

Vericel Corporation VCEL · Healthcare · 46 filings in 24 months ticker →

Healthcare · Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jonathan Mark Hopper in VCEL

VCELSALE Vericel Corporation $450K
10,000 sh across 2 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET VCELSALE Vericel Corporation $153K
4,375 sh × $35.00
Exec Jun 2
Filed Jun 4 · 5:30 PM ET VCELSALE Vericel Corporation $122K
3,472 sh × $35.00
Exec Apr 2
Filed Apr 6 · 5:30 PM ET VCELSALE Vericel Corporation $401K
10,000 sh × $40.09
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET VCELSALE Vericel Corporation $495K
10,000 sh × $49.53
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET VCELSALE Vericel Corporation $587K
10,000 sh × $58.72
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET